Citation Impact
Citing Papers
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial
2010
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
TNF inhibitor therapy for rheumatoid arthritis
2012
Macrophages in immunoregulation and therapeutics
2023 Standout
Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Rheumatoid Arthritis by Bioinformatics Analysis
2021
Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory Diseases
2012
Psoriasis
2021 Standout
IL-6 as a keystone cytokine in health and disease
2015 Standout
High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis
2014
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
B cells
2013
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
2011
Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab
2012
Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease
2011
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial
2010
Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony
2019 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
2018
A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
2015
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
T‐cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man
2012 StandoutNobel
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
TNF Inhibitor Therapy for Rheumatoid Arthritis
2012
Therapeutic Targeting of the Interleukin-6 Receptor
2011
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab
2012
Works of Stefan Kleinert being referenced
In vivo effects of the anti–interleukin‐6 receptor inhibitor tocilizumab on the B cell compartment
2011
Psoriatic arthritis: therapeutic principles
2008
Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study
2011
Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells
2011
T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy
2019